Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
about
Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinomaDiagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.The role of epigenetic transcription repression and DNA methyltransferases in cancer.DRP-1, ezrin and E-cadherin expression and the association with esophageal squamous cell carcinomaIdentification of a novel methylated gene in nasopharyngeal carcinoma: TTC40Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study.Distinct profiles of epigenetic evolution between colorectal cancers with and without metastasis.Clinical utility of RASSF1A methylation in human malignancies.Relationship between gene expression and the accumulation of catechin during spring and autumn in tea plants (Camellia sinensis L.).Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma.Reduced expression levels of the death-associated protein kinase and E-cadherin are correlated with the development of esophageal squamous cell carcinomaTumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinomaQuantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA).Role of DNA methylation in head and neck cancer.Evaluating DAPK as a therapeutic target.Hypermethylation of tumor-related genes in Tunisian patients with gastric carcinoma: clinical and biological significance.Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.The identification and evaluation of two different color variations of tea.Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma.Diagnostic potential of methylated in brushing samples of nasopharyngeal carcinoma
P2860
Q33601450-065A64F8-F98D-4090-A376-60D83B477BE0Q33603685-3D43206E-05F5-4B27-B722-35F643D65C26Q33718270-2CA97549-8299-4086-86D6-80CD0F7DAB10Q33778529-11716F8D-1AF6-4823-8EB8-5FC5BBF9648CQ33912110-19EB1CE8-3B7E-4B2C-893E-A7301E0131B5Q34014559-08BBCD96-F0C9-4DBA-A059-AA5FB1063159Q34699520-1966BC52-CB97-4884-B825-669122717A36Q34777413-624CC477-8683-4682-8AE5-E40C3327145FQ34805590-18C30B09-9FBA-46E0-AD95-9B07F50CA044Q35909621-FA31B786-A763-411B-9472-06D5BD408408Q36129614-7693B183-BEBC-42AD-9A74-D487B5F5E7DEQ36544611-78725218-758A-43A2-9A55-73ACACB02CFFQ36604023-F2821397-C6C1-420F-BF45-C17B75A88432Q37183789-3450C2E4-418D-4AF4-B4AB-08A6456231A7Q37656296-41EA9A86-D69A-4997-92A6-F7E159B20996Q38019157-8E114E3A-762B-4448-8947-935D091E3073Q38168688-30191E2B-707D-49E3-AFE3-41B8EF81E3F7Q38901851-A4709966-E950-4199-84B4-B59F1D36D0FFQ38959017-B90559CA-5A3D-42A9-8CC7-3020A7A4C5ABQ46471354-B1078D06-8195-4752-B207-937042564E0AQ48233194-6209D376-E00C-46AD-9C23-24E9BE181849Q58698636-8CBAE357-7B15-47F9-B6F3-FEE8A1E03DC7
P2860
Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Inactivation of RASSF1A, RARbe ...... s in nasopharyngeal carcinoma.
@en
Inactivation of RASSF1A, RARbe ...... s in nasopharyngeal carcinoma.
@nl
type
label
Inactivation of RASSF1A, RARbe ...... s in nasopharyngeal carcinoma.
@en
Inactivation of RASSF1A, RARbe ...... s in nasopharyngeal carcinoma.
@nl
prefLabel
Inactivation of RASSF1A, RARbe ...... s in nasopharyngeal carcinoma.
@en
Inactivation of RASSF1A, RARbe ...... s in nasopharyngeal carcinoma.
@nl
P2093
P356
P1476
Inactivation of RASSF1A, RARbe ...... s in nasopharyngeal carcinoma.
@en
P2093
Abdelmajid Khabir
Abdelmonem Ghorbel
Ali Fendri
Ali Gargouri
Asma Masmoudi
Jamel Daoud
Mounir Frikha
Raja Mokdad-Gargouri
Tahia Sellami-Boudawara
P304
P356
10.4161/CBT.8.5.7686
P577
2009-03-21T00:00:00Z